Dr Annabelle Morgan

Dr. Annabelle is a scientist and educator who earned a PHD from Vanderbilt University with a Doctor of Philosophy (PhD), Cell and Developmental Biology Doctor of Philosophy with a focus on Cardio-Oncology (PhD) in 2017. Prior to that, she also earned a degree from Georgetown University in Neuroscience in 2012. Dr. Annabelle is currently an entrepreneur focused on the field of pharmaceutical innovation and clinical trial medical research in the cannabis industry. Currently, she is the lead scientist for Flora Growth, the parent company of JustCBD.

● Visiting Scientist, Vanderbilt University Medical Center
· Full-time, Oct 2021 – Present · 9 months

● Member Board Of Directors, Flora Growth (FLGC)
· Full-time, Oct 2021 – Present · 9 months

● Scientific Advisor, Quanta Inc.
· Full-time, Apr 2019 – Present · 3 years

Founder & Chief Scientific Officer, Masaya Medical
· Full-time, Jul 2016 – Present · 6 years

I developed a cannabidiol medicine (Masaya CBD 3000) as an alternative treatment for my recovering son. Read our story “Crafting Cannabis: A Modern-Day Lorenzo’s Oil” published in Forbes for details. I have initiated Phase IV clinical trials and numerous studies to determine the safety and efficacy of cannabinoids in treatment of human conditions and disease states. Additionally, I am collaborating with scientists and institutions across the world to conduct studies utilizing cannabidiol medicine.

I researched and developed a cannabidiol medicine (Masaya CBD 3000) as an alternative treatment for my son to manage his brain seizures. Read our story “Crafting Cannabis: A Modern-Day Lorenzo’s Oil” published in Forbes for details. I have initiated Phase IV clinical trials and numerous studies to determine the safety and efficacy of cannabinoids in the treatment of human conditions, including lethal diseases. Additionally, I am collaborating with scientists and institutions across the world to conduct important studies on cannabis and the human body.